Literature DB >> 23024333

Diagnosing COPD and targeted lung cancer screening.

Robert P Young, Raewyn J Hopkins.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23024333     DOI： 10.1183/09031936.00070012

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.

Authors:  Raewyn J Hopkins; Fenghai Duan; Caroline Chiles; Erin M Greco; Greg D Gamble; Denise Aberle; Robert P Young
Journal:  Ann Am Thorac Soc       Date:  2017-03

Review 2.  Screening for lung cancer.

Authors:  Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal:  Cochrane Database Syst Rev       Date:  2013-06-21

3.  Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

Authors:  Juan P de-Torres; David O Wilson; Pablo Sanchez-Salcedo; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Marta García-Granero; Bartolome R Celli; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

4.  Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.

Authors:  Robert P Young; Fenghai Duan; Caroline Chiles; Raewyn J Hopkins; Greg D Gamble; Erin M Greco; Constantine Gatsonis; Denise Aberle
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

5.  Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.

Authors:  Kathryn P Lowry; G Scott Gazelle; Michael E Gilmore; Colden Johanson; Vidit Munshi; Sung Eun Choi; Angela C Tramontano; Chung Yin Kong; Pamela M McMahon
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

6.  Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France.

Authors:  Sylvie Leroy; Jonathan Benzaquen; Andrea Mazzetta; Sylvain Marchand-Adam; Bernard Padovani; Dominique Israel-Biet; Christophe Pison; Pascal Chanez; Jacques Cadranel; Julien Mazières; Vincent Jounieaux; Charlotte Cohen; Véronique Hofman; Marius Ilie; Paul Hofman; Charles Hugo Marquette
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

Review 7.  Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective.

Authors:  Jie Dai; Ping Yang; Angela Cox; Gening Jiang
Journal:  Oncotarget       Date:  2017-03-14

8.  Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.

Authors:  Stephen G Spiro; Pallav L Shah; Robert C Rintoul; Jeremy George; Samuel Janes; Matthew Callister; Marco Novelli; Penny Shaw; Gabrijela Kocjan; Chris Griffiths; Mary Falzon; Richard Booton; Nicholas Magee; Michael Peake; Paul Dhillon; Kishore Sridharan; Andrew G Nicholson; Simon Padley; Magali N Taylor; Asia Ahmed; Jack Allen; Yenting Ngai; Nyasha Chinyanganya; Victoria Ashford-Turner; Sarah Lewis; Dahmane Oukrif; Pamela Rabbitts; Nicholas Counsell; Allan Hackshaw
Journal:  Eur Respir J       Date:  2019-10-17       Impact factor: 16.671

9.  Identification of dynamic signatures associated with smoking-related squamous cell lung cancer and chronic obstructive pulmonary disease.

Authors:  Xiaoru Sun; Jingzhe Shang; Aiping Wu; Jingyan Xia; Feng Xu
Journal:  J Cell Mol Med       Date:  2019-12-12       Impact factor: 5.310

10.  Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.

Authors:  R P Young; R J Hopkins; G D Gamble
Journal:  Front Genet       Date:  2012-10-16       Impact factor: 4.599
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.